The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    Consumer Alert: Hyland’s Teething Tablets

    Oh, Oh. They added belladonna.

    FDA found that this homeopathic product contains inconsistent amounts of belladonna, and using it may pose a risk to children.

    Here’s what we know.

    • There have been reports of serious adverse events in children taking Hypand’s Teething Tablets that are consistent with belladonna toxicity.
    • The FDA has also received reports of children who consumed more tablets than recommended, because the containers do not have child resistant caps.

    The bottom line?

    FDA recommends that consumers not use this product and dispose of any in their possession.

    Consult your healthcare professional if your child experiences symptoms such as seizures, difficulty breathing, lethargy, excessive sleepiness, muscle weakness, skin flushing, constipation, difficulty urinating, or agitation after using Hyland’s Teething Tablets.

    Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of this product to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program.

    10/24/10 15:08 JR

    Leave a Comment

    You must be logged in to post a comment.